173 related articles for article (PubMed ID: 8568563)
1. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
Odake S; Kam CM; Powers JC
J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
[TBL] [Abstract][Full Text] [Related]
2. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
Tans G; Janssen-Claessen T; Rosing J; Griffin JH
Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of tripeptide chloromethyl ketones and examination of their inhibitory effects on plasmin and plasma kallikrein.
Tsuda Y; Teno N; Okada Y; Wanaka K; Bohgaki M; Hijikata-Okunomiya A; Okamoto U; Naito T; Okamoto S
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3108-11. PubMed ID: 2534361
[TBL] [Abstract][Full Text] [Related]
4. Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.
Bock PE
Biochemistry; 1988 Aug; 27(17):6633-9. PubMed ID: 3219359
[TBL] [Abstract][Full Text] [Related]
5. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. I. Specificity of thrombin labeling.
Bock PE
J Biol Chem; 1992 Jul; 267(21):14963-73. PubMed ID: 1634535
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of peptides of arginine chloromethyl ketone. Selective inactivation of human plasma kallikrein.
Kettner C; Shaw E
Biochemistry; 1978 Oct; 17(22):4778-84. PubMed ID: 728386
[TBL] [Abstract][Full Text] [Related]
7. Immobilization of the irreversible thrombin inhibitor D-Phe-Pro-Arg-chloromethylketone: a concept for hemocompatible surfaces?
Maitz MF; Sperling C; Werner C
J Biomed Mater Res A; 2010 Sep; 94(3):905-12. PubMed ID: 20730927
[TBL] [Abstract][Full Text] [Related]
8. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
9. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
Ofosu FA; Hirsh J; Esmon CT; Modi GJ; Smith LM; Anvari N; Buchanan MR; Fenton JW; Blajchman MA
Biochem J; 1989 Jan; 257(1):143-50. PubMed ID: 2920007
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of subtilisin BPN' with peptide chloromethyl ketones.
Powers JC; Lively MO; Tippett JT
Biochim Biophys Acta; 1977 Jan; 480(1):246-61. PubMed ID: 831835
[TBL] [Abstract][Full Text] [Related]
11. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases.
Bock PE
J Biol Chem; 1992 Jul; 267(21):14974-81. PubMed ID: 1634536
[TBL] [Abstract][Full Text] [Related]
12. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.
Brandstetter H; Bauer M; Huber R; Lollar P; Bode W
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9796-800. PubMed ID: 7568220
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombin.
Callas D; Bacher P; Iqbal O; Hoppensteadt D; Fareed J
Thromb Res; 1994 May; 74(3):193-205. PubMed ID: 8042188
[TBL] [Abstract][Full Text] [Related]
14. Mechanism-based isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substituent in 7-amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on inhibitory and anticoagulant potency.
Kam CM; Kerrigan JE; Plaskon RR; Duffy EJ; Lollar P; Suddath FL; Powers JC
J Med Chem; 1994 Apr; 37(9):1298-306. PubMed ID: 8176707
[TBL] [Abstract][Full Text] [Related]
15. Amino acids and peptides. XXXVI. Synthesis of enkephalin chloromethyl ketone and evaluation of its inhibitory activity against endopeptidase 22.19.
Taguchi H; Nishiyama Y; Camargo AC; Okada Y
Chem Pharm Bull (Tokyo); 1993 Nov; 41(11):2038-9. PubMed ID: 8293527
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.
Ofosu FA; Sie P; Modi GJ; Fernandez F; Buchanan MR; Blajchman MA; Boneu B; Hirsh J
Biochem J; 1987 Apr; 243(2):579-88. PubMed ID: 2443128
[TBL] [Abstract][Full Text] [Related]
17. Kinetic properties of tripeptide lysyl chloromethyl ketone and lysyl p-nitroanilide derivatives towards trypsin-like serine proteinases.
Collen D; Lijnen HR; De Cock F; Durieux JP; Loffet A
Biochim Biophys Acta; 1980 Sep; 615(1):158-66. PubMed ID: 6448639
[TBL] [Abstract][Full Text] [Related]
18. Inhibited thrombins. Interactions with fibrinogen and fibrin.
Kaminski M; McDonagh J
Biochem J; 1987 Mar; 242(3):881-7. PubMed ID: 3593282
[TBL] [Abstract][Full Text] [Related]
19. Biotin derivatives of D-Phe-Pro-Arg-CH2Cl for active-site-specific labeling of thrombin and other serine proteinases.
Anderson PJ; Bock PE
Anal Biochem; 2001 Sep; 296(2):254-61. PubMed ID: 11554721
[TBL] [Abstract][Full Text] [Related]
20. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
